← All modules
Treatment Algorithm · Module
Implants in diabetes: let glycemic control set the timeline
Perioperative management of the patient with diabetes. Well-controlled diabetes is not a contraindication to implants; outcomes track glycemic control rather than the diagnosis itself. HbA1c stratifies whether to proceed, optimize first, or defer.
Use: Risk-stratification reference
Key gate: HbA1c
Co-manage: Patient's physician
01 — Classification
Glycemic control bands
Control is graded by glycated hemoglobin (HbA1c). Well-controlled patients achieve implant survival comparable to non-diabetic patients; outcomes deteriorate progressively as HbA1c rises.
Band A
Well-controlled
- HbA1c ≤ 7% (commonly cited up to ~8%)
- Survival comparable to non-diabetic patients (~95–97%)
- Healing and osseointegration essentially normal
- Not a contraindication to implant therapy
Band B
Moderately controlled
- HbA1c 7–8%
- Acceptable but with somewhat higher risk
- Optimize control where reasonable before surgery
- Reinforce anti-infective measures
Band C
Poorly controlled
- HbA1c > 8%
- Delayed healing, higher infection & bone-loss risk
- Worse peri-implant outcomes as HbA1c climbs
- Defer elective surgery until improved
02 — Decision Pathway
Interactive control selector
Use a recent HbA1c (ideally within ~3 months) together with the day-of-surgery glucose. Thresholds are guidance, not absolutes — individualize with the patient's physician.
Tap the patient's current glycemic-control band.
Step 1 — What is the most recent HbA1c?
WELL
HbA1c ≤ 7% (up to ~8%)
Stable control, no acute hyperglycemia.
MODERATE
HbA1c 7–8%
Borderline; room to optimize.
POOR
HbA1c > 8%
Uncontrolled; elevated complication risk.
▾
03 — Quick Reference
HbA1c band → recommendation
Anti-infective measures (perioperative antibiotics where indicated, chlorhexidine, scrupulous asepsis) and good glucose control on the day of surgery apply across all bands.
| HbA1c band | Risk | Recommendation |
|---|
| ≤ 7% (well) | Comparable to non-diabetic | Proceed with routine perioperative care and follow-up. |
| 7–8% (moderate) | Slightly elevated | Proceed if stable; optimize control where feasible; reinforce anti-infective protocol. |
| > 8% (poor) | High | Defer elective surgery; refer to physician to improve control first. |
| Day-of glucose | Acute factor | Confirm acceptable perioperative glucose; postpone if markedly hyperglycemic. |
| Infection control | All patients | Asepsis, chlorhexidine, antibiotics where indicated; close monitoring of healing. |
Reference
Sources & clinical disclaimer
For licensed clinicians — educational use only. This algorithm summarizes published evidence and is not a substitute for individual clinical judgment, examination, or the standard of care in your jurisdiction. HbA1c cut-offs vary across guidelines and evidence is heterogeneous. Coordinate with the patient's physician on glycemic optimization and perioperative management before and after surgery.
- Naujokat H, Kunzendorf B, Wiltfang J. Dental implants and diabetes mellitus — a systematic review. Int J Implant Dent. 2016;2(1):5.
- Al Ansari Y, et al. Success Rates of Dental Implants in Patients With Diabetes: A Systematic Review. Cureus. 2024;16(12):e76078.
- Jiang X, et al. Systematic review on diabetes mellitus and dental implants: an update. Int J Implant Dent. 2021;7(1):78.
Last reviewed: June 2026 · Next review due: June 2027 · Version 1.0